Discover and share with your network the new brochure of BioFIT 2017. Download it now!

Looking forward to welcoming you on 28 and 29 November 2017, in Strasbourg!

For more information, please contact Margaux Satolamsatola@eurasante.com | +33 (0)3 59 39 01 82

We are very pleased to count Pfizer among the Sponsors of BioFIT.

As Pfizer, join the BioFIT Sponsors and get the opportunity to:

  • Associate your image to the main partnering event in Europe dedicated to tech transfer and academia-industry collaborations in Life Sciences
  • Reassert your focus on early stage innovation
  • Bring out your ideas and technologies to the key players of innovation in Life Sciences

Discover all the sponsorship opportunities.

Please contact Margaux Satola to receive a tailored offer that best meets your needs and expectations:

msatola@eurasante.com | +33 (0)3 59 39 01 82

BioFIT Steering Committee gathered last week to design a brand new conference programme for its 2017 edition. Always aiming at fulfilling our audience’s expectations and fit at best its concerns, our experts rethought the overall organisation and topics of the sessions. 

Organised around 3 brand new reshaped tracks, BioFIT 2017 conference programme is designed to address the needs of its varied and diverse audience. Appealing to academia, TTOs, research institutions, pharmas, biotechs, but also law experts and investors in seed and series A, BioFIT 2017 programme will be organised around the following axis:

 

  • Track 1: New players and new sources in the health sector
  • Track 2: Maturing and licensing early-stage assets
  • Track 3: Bioentrepreneurs’ challenges at seed stage and Series A.

 

This meeting was also the occasion to define this year’s awaited plenary session.

Scheduled on November 28th from 11.00 am to 12.30 pm in Strasburg, we will have the pleasure to see heavy-league speakers debate :

“How to promote in Europe a culture of entrepreneurship?”

 

We can’t wait to tell you more about the programme, that will be issued shortly.

In the meantime, go check BioFIT 2016 Conference programme

 

Want to speak at BioFIT ? Contact Claire

BioFIT is proud to host the 3rd edition of the “R&D dating for animal health and innovation”, initiated by the French association for animal health industry (SIMV).

Two days of networking and face-to-face meetings between research departments of the veterinary medicine and diagnostics industry and public research, as well as biotechnology companies. Some conferences will deal with animal health.

100 delegates / 30 companies / 40 academic teams attendees

To know more about this hosted event, please click here.

 

Interested in hosting your own event during BioFIT?

Please contact: Margaux Satola | msatola@eurasante.com | +33 (0)3 59 39 01 82

On Thursday 23rd February, BioFIT team will be in Paris to attend Techinnov.

Take advantage of that perfect opening to get an extensive overview of BioFIT activities or just have a chat with our team!

Contact: Otmane Lahgui | olahgui@eurasante.com | +33 (0)3 28 55 90 67

On Thursday 9th February, our prestigious Steering Committee will meet in Paris to talk about BioFIT 2017.

First of all, we are honored to welcome new members in the Steering Commitee for the 2017 edition:

  • Nadine Weisslinger-Darmon, Medical Director Specialty Products, Clinical Research and Academic Alliances, from GSK
  • Cédric Barrière, Director, External Innovation Oncology, External Science and Partnering, from Sanofi
  • Pascal Raoul, Scientific and Innovation Director, from CEVA
  • Christian Policard, Member of the Board, Chairman of the Business Development Sub-Committee, from France Biotech

Composed of high level representations from leaders of the Life Sciences industry: Pfizer, Roche, Boehringer Ingelheim, Ipsen, Novo Nordisk, LFB, TTOs and Academics: Ascenion, Max Planck Institute of Molecular Cell Biology and Genetics, SATT Conectus Alsace, SATT Nord as well as Associations, Clusters, Investors & Law Firms: Sofinnova Partners, Alsace BioValley, De Gaulle Fleurance & Associés, EBE – European Biopharmaceutical Enterprises.

This BioFIT Steering Committee meeting will be the perfect way for these renowned experts to further discuss about the 2017 conference programme and identify top-notch potential speakers for the roundtable discussions.

 Let’s keep in touch after it for more information!

“First-come, first-served”, this could be the mantra for BioFIT 2017 exhibition area.

Exhibiting at BioFIT will allow you to gain in visibility among more than 1,200 actors of the sector, to maximise your business opportunities and develop your network.

Book your stand now (from 6 m² to 18 m²) and benefit from an ideal location in the heart of the leading partnering event in Europe for technology transfer, academia-industry collaborations and early stage innovation in the field of Life Sciences.

Check out the exhibition fees here

Contact us now to book your booth for BioFIT 2017: Margaux Satola // msatola@eurasante.com // +33 (0)3 59 39 01 82

More than 1,100 delegates, over 30 countries represented, 90 exhibitors, 60 international speakers, 13 roundtable discussions and 6 hosted events: BioFIT has reached a critical mass in only five editions. With these figures, BioFIT has confirmed its position as the leading event for tech transfer, academia-industry collaborations and sourcing early stage innovations in the field of life sciences. BioFIT is also becoming the marketplace for seed and Series A investment.

It is the only event that gathers big pharma, biotech start-ups and SMEs, researchers and investors in the same place at the same time, focused on the same goals: Engage new partnerships, source innovative and competitive early stage R&D projects, facilitate the emergence of collaborative projects and increase licensing opportunities in life sciences.

A winning bet

In only five editions, BioFIT has quadrupled its number of attendees, convinced other organisations to host their events and has most importantly, become an annual event. To continue its growth, the organisers of BioFIT have decided to engage in a long-term partnership with the Alsace BioValley competitiveness cluster. The Lille-Strasbourg rotation began in 2015.

Choosing the Alsace region was obvious, given its European and international openness and its high research potential in the healthcare sector”, explained Mr. Etienne Vervaecke, General Manager of Eurasanté and the NHL Cluster and General Commissioner for BioFIT.

The secret of our success

The close co-operation between the economic development agency and two competitiveness clusters to ensure the successful organisation of the event is worthy of mention. This unique combination benefits the regions’ competitiveness. BioFIT is the only event that gathers public and private actors at its business convention and technology presentation sessions. The comprehensive conference programme covers on-trend topics of interest and answers key questions about the best practices in collaborative research, technology transfer and early stage financing innovation.

Identifying TT professionals at the business convention

In addition to scheduling business meetings, the partnering platform allowed participants to propose licensing opportunities. At this 5th edition, nearly 800 opportunities were published and more than 75% of them were projects to transfer licences.

With 20% of attendees coming from pharma, including the Big Pharma Top 20, 30% from academia and TTOs, 20% from emerging biotechs and 10% from investors, BioFIT has confirmed its position as the leading international event in the sector.

Participants included:

·                Big and medium pharmas: Sanofi, AbbVie, Roche, GSK, Pfizer, Bayer, Novo Nordisk, LFB, Boehringer Ingelheim, Lilly, AstraZeneca, J&J, Merck and Ipsen Innovation

·                Biotechs: Zoetis, AlzProtect, Galapagos, Hybrigenics, Nanobiotix, Yaqrit, Ixaltis, Lipigon, Cellectis, TxCell and Onxeo
TTOs, Universities: Ascenion, Max Planck Institute, CEA Tech, SATT network, VIB, Isis Innovation, Harvard Tech Transfer Office, Ramot and the University of Ghent

·                Associations, professional networks: Aviesan, European Biotechnology Network, France Biotcech, EuropaBio, ASTP-Proton, EBE-EFPIA, Réseau C.U.R.I.E., SIMV, ASEBIO, Swiss Biotech Association, LISA and the UK Innovation Forum

·                Investors: Kurma Partners, Medxci Omnes, Capital, European Investment Fund, London Stock Exchange, Fund+, Merck Ventures, Sofinnova Partners and Novo Seeds

BioFIT is also becoming the marketplace for seed investment in cutting-edge technologies.
Distinguished speakers

Pfizer, Nanobiotix, VIB, The Max Planck Society, Evotec, Roche Innovation Center, Medixci, Novo Seeds, Kurma Partners and Fund+ – These are just a few examples of the 60 international organisations (including speakers from the USA, Canada, Israel, South Korea, Japan) who discussed current topics and answered key questions about best practices in collaborative research, key issues in technology transfer and licensing and early stage financing innovation.

An exhibition that continues to grow

The Business Convention is at the heart of the event, but the exhibition is also a key part of BioFIT. It has quadrupled its attendance, from 20 international exhibitors and co-exhibitors in 2010 to 90 this year, which clearly shows the actors’ wish is to be increasingly present and visible.

In the 700m² exhibition area, participants could meet Northern French SMEs such as OCR, 4P-Pharma, Aquilab, E-Zyvec or Genoscreen, the Dutch ASTP-Proton, ALCAMI Corporation or MyCartis, the Finnish Admescope, the Czech CzechInvest, the Estonian GeneCode, the Swiss Baccinex and Bachem AG, the Belgian KIC-Europe, EU-Japan, or structures such as the SIRIC ONCOLille, the SIMV and EGID.

Six hosted events: BioFIT brings numerous organisations together

Once again, BioFIT hosted six events, with one objective: Support and facilitate collaborative research by fostering public/private collaborations.

Between 29th November and 1st December, the following events took place: The 4th edition of IDEA Summit, the 2nd Techno Market and Licensing Opportunity Presentations, the Start-up Slams, the AFSSI Conference, the SIRIC ONCOLille Days and the 4th edition of the EGID Symposium.

 

Save the date for the 6th edition of BioFIT:

28th and 29th November 2017 in Strasbourg, France

Date & Time: 1st Dec, 11.30 am – 1.00 pm  – Matisse 1/2 abbvie
 

Universities – a short or long-term partner for spin-offs?

 

How does a university decide on its involvement with a spin-off? How do universities handle IP transfer and POC funding? Our panelists will share best practices from their experience of previous and current collaborations. Are there better ways to collaborate on the long-term? Can we choose between long-term or short-term? Is there a different relationship to each case? Is it better to stay friends and call it quit ? Should we define from the beginning what the length of the collaboration will be?

Come and listen to our international panelists discuss this inspiring question, in a session sponsored by AbbVie!

Moderator: Alexandra Carrel, Certified Licensing Professional, Cabinet Carrel (FR)

  • Paul Ashley, Deputy Head of Tech Transfer, Isis Innovation (UK)
  • Stefan K. Nilsson, CEO, Lipigon (SE)
  • Adi Elkeles, VP Business Development Life Sciences, Ramot (IL)
  • Olga Kubassova, CEO, Image Analysis Group (DE)

 

Hurry up! The deadline to submit requests/acceptances to be included in the first round of scheduling is planned on Tuesday 22nd November.

So send now the maximum of meeting requests to your future partners!

If you are not yet registered for BioFIT 2016, do it now! After it will be too late…

Contact: Margaux Satola | msatola@eurasante.com | +33 359 390 182